View Older Stories

Oct 20, 2025 08:31AM Quantum BioPharma warrants expire, confirms CVR record date

Oct 14, 2025 08:15AM Quantum BioPharma disputes law firm securities investigation claims

Oct 8, 2025 08:03AM Quantum BioPharma offers $7 million reward for stock manipulation proof

Oct 7, 2025 11:01AM Quantum BioPharma gets dual listing on Upstream digital exchange

Oct 7, 2025 11:00AM Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Oct 3, 2025 07:01AM Quantum BioPharma sets record date for litigation-linked dividend rights

Oct 1, 2025 07:50AM Quantum BioPharma adds multiple sclerosis expert as clinical advisor

Sep 29, 2025 07:44AM Quantum BioPharma shareholders approve board nominees and auditor

Sep 28, 2025 11:28AM Quantum BioPharma grants stock options and restricted share units

Sep 26, 2025 08:00PM Quantum BioPharma Announces Corporate Updates

Sep 18, 2025 08:10AM Quantum BioPharma receives Health Canada license for Qlarity supplement

Aug 11, 2025 06:34PM Quantum BioPharma seeks shareholder approval for $600 private placement

Aug 11, 2025 06:32PM Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 8, 2025 08:01AM Quantum BioPharma reports progress on PET tracer for multiple sclerosis

Aug 7, 2025 07:01AM Quantum BioPharma reports Q2 gains with debt conversion to equity

Aug 4, 2025 07:33AM Quantum BioPharma files court response in $700 million lawsuit against banks

Jul 22, 2025 08:52AM Quantum BioPharma invests in 2,000 GameStop shares

Jul 8, 2025 08:11AM Quantum BioPharma (QNTM) submits multiple sclerosis drug to UK fast-track program

Jun 27, 2025 04:30PM Quantum BioPharma (QNTM) Announces Private Placement

Jun 26, 2025 07:30AM Quantum BioPharma (QNTM) Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 18, 2025 09:19AM Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 17, 2025 08:00AM Quantum BioPharma (QNTM) Announces First Person with Multiple Sclerosis Scanned in Joint Study with Massachusetts General Hospital

Jun 13, 2025 07:01AM Quantum BioPharma (QNTM) to Declare Special Dividend of Contingent Value Rights Linked to Future Litigation Settlement Proceeds

Jun 10, 2025 08:00AM Quantum BioPharma (QNTM) Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000

Jun 3, 2025 07:50AM Quantum BioPharma (QNTM) Clarifies It Has Not Changed Its Name

May 30, 2025 07:00AM Quantum BioPharma (QNTM) Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 29, 2025 07:31AM Quantum BioPharma (QNTM) Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 28, 2025 08:00AM Quantum BioPharma (QNTM) Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202

May 21, 2025 08:06AM Quantum BioPharma (QNTM) Partners with BitGo to Securely Store its Crypto Currency Assets

May 20, 2025 07:31AM Quantum BioPharma (QNTM) Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND

May 19, 2025 07:30AM Quantum BioPharma (QNTM) Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies

May 12, 2025 08:04AM Quantum BioPharma (QNTM) Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

Apr 22, 2025 07:00AM Quantum BioPharma (QNTM) Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

Apr 18, 2025 08:00PM Quantum BioPharma Corporate Update

Apr 14, 2025 07:30AM Quantum BioPharma (QNTM) Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario

Apr 10, 2025 07:30AM Quantum BioPharma (QNTM) Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council

Apr 3, 2025 07:01AM Quantum BioPharma (QNTM) Licensee Celly Nutrition Launches unbuzzd in Puerto Rico

Mar 31, 2025 07:03AM Quantum BioPharma (QNTM) Closes $2.42M Tranche of $5M Total Financing on Improved Terms

Mar 30, 2025 07:00PM Quantum BioPharma Provides Corporate Update

Mar 28, 2025 09:16AM Quantum BioPharma (QNTM) Reports Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Mar 28, 2025 09:15AM Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Mar 27, 2025 07:00AM Quantum BioPharma (QNTM) Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors

Mar 20, 2025 07:30AM Quantum BioPharma (QNTM) Buys Another $1,500,000 Worth of Bitcoin and Other Cryptocurrencies

Mar 17, 2025 03:35PM Quantum BioPharma (QNTM) Unaware of Any Material Change

Mar 17, 2025 03:33PM Quantum BioPharma Unaware of Any Material Change

Mar 7, 2025 08:00PM Quantum BioPharma Provides Corporate Update

Feb 18, 2025 07:30AM Quantum BioPharma (QNTM) Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies

Feb 10, 2025 07:30AM Quantum BioPharma (QNTM) Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs

Feb 6, 2025 07:32AM Quantum BioPharma (QNTM) Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzz

Feb 4, 2025 07:03AM Quantum BioPharma (QNTM) Announces the Success of unbuzzd Clinical Trial

View Older Stories